Biomerica Says Japan OKd Its Prostate Test

Biomerica Inc., a Newport Beach medical technology company, said Monday that the Japanese Ministry of Health has approved the company’s disposable prostrate cancer screening test for distribution and marketing.

The company said in a press release that the 10-minute test is designed to detect elevated blood levels of prostate specific antigen, an early warning indicator of prostate cancer.